TWENTE published: Resolute matches Xience V stent TheHeart.Org Enschede, the Netherlands - Data from the TWENTE trial, a study showing that the Resolute zotarolimus-eluting stent (Medtronic) was noninferior to the Xience everolimus-eluting stent (Abbott) in the treatment of "real-world" patients with complex ... |
